Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Trial of Parkinson's Disease Treatment by Human-induced Pluripotent Stem Cells (hiPSCs) Derived Dopaminergic Neural Precursor Cells

NCT06145711 is registered in ClinicalTrials.gov with Shanghai East Hospital as lead sponsor.

NCT NCT06145711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06145711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Trial of Parkinson's Disease Treatment by Human-induced Pluripotent Stem Cells (hiPSCs) Derived Dopaminergic Neural Precursor Cells
Lead sponsor
Shanghai East Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
November 23, 2023
Completion date
December 22, 2025
Enrollment
3 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease